CergenX
PrivateLast Round
Grant
Nov 28, 2023
Total Funding Raised
$8.14M
Company Overview
CergenX operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Grant round in November 2023.
CergenX is a medtech company that provides an artificial intelligence (AI)-based clinical assessment platform designed to support early detection and monitoring of brain injury in newborns.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CergenX Comparables
Compare CergenX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroBell | 94% | |
| Wavelet Medical | 82% | |
| Neolook Solutions | 71% |
For institutional investors. Book with your work email.
CergenX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 28, 2023 | ||||
| Private Placement | Jul 7, 2023 | ||||
| Seed | Jul 5, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CergenX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Disruptive Technologies Innovation Fund | Grant |
| Enterprise Ireland | Private Placement, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Grew 73% QoQ, from 11 to 19 employees.
- Jan 1, 2026
Monthly visitors increased 322% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 6, 2026
Cergenx Ltd receives CE Mark certification for Wave, its AI-powered technology that delivers rapid, objective insight into newborn brain activity and clears the way for commercialization across Europe.
- attends_eventAug 31, 2026
Cergenx Ltd represents itself at the invitation-only MDR/IVDR 2.0 Summit in France.
For institutional investors. Book with your work email.
CergenX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CergenX's valuation, stock price, and market status.
Is CergenX a public or private company?
CergenX is a private company.
What is the current stock price of CergenX?
CergenX is a private company, so its shares have no public market price. Caplight tracks CergenX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CergenX worth (valuation)?
Valuation information for CergenX is not publicly available.
Can I buy CergenX stock?
CergenX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CergenX's last funding round?
CergenX's most recent funding round was Grant on November 28, 2023.
Who are the main investors in CergenX?
Key investors in CergenX include Disruptive Technologies Innovation Fund, Enterprise Ireland.
Will CergenX IPO soon?
No public IPO plans have been announced for CergenX.
How can I track CergenX secondary market activity?
Caplight tracks bids, offers, and trades in CergenX's shares on secondary markets.